
View larger version (62K):
[in a new window]
|
Fig. 2. Localisation of Chs2p depends on the general system for polarised growth, CAR assembly, and a functional SIN pathway. (A) cdc25-22 cells carrying the Chs2-GFP fusion protein were arrested at 37°C and then released at 25°C in the presence of DMSO (upper panels) or 100 µM latrunculin A (lower panels); the cells were imaged after 75 minutes at 25°C. The micrographs show DAPI and Calcofluor (Cf) staining (left panels), Chs2-GFP (central panels) or Rhodamine-phalloidin staining (right panels; F-actin). (B) An asynchronous culture was treated with DMSO (upper panels) or with 100 µM latrunculin A (lower panels). The cells shown were imaged after 20 minutes; cell wall and nuclei (left panels); Chs2-GFP (central panels); F-actin (right panels). (C-H) Analysis of nuclei and cell walls (DAPI/Cf; left panels) and the distribution of the Chs2-GFP (right panels) in the indicated strains incubated at the corresponding restrictive temperatures or at the temperature indicated for specific cases. In all cases the asterisks indicate the midzone of cells in which a new septum is being synthesized but in which the Chs2-GFP ring cannot be observed. (C) WT strain incubated at 37°C. (D) Myosin V mutant myo52 . The arrowhead points to the midzone of a septating cell in which the Chs2-GFP signal is observed but shows an aberrant thread-like distribution. (E) Exocyst mutant exo70 . The arrowhead points to a cell (incubated at 37°C) in which there is a weak Chs2-GFP signal in a forming ring. The diamond marks Chs2-GFP abnormal maintenance at the medial region of a cell in which the septum has been completed. (F) Analysis of mutants defective in type-II myosins: cdc4-8, rlc1 , myo3 or myo2-E1 myo3 . The arrowhead in the right myo3 panel indicates a spot of Chs2-GFP intracellular localisation. (G) cdc15-140 mutant, defective in CAR assembly. (H) SIN mutants cdc11-119 or cdc16-116. Bar, 10 µm.
|